Huaren Pharmaceutical Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Huaren Pharmaceutical has a total shareholder equity of CN¥2.8B and total debt of CN¥986.7M, which brings its debt-to-equity ratio to 34.8%. Its total assets and total liabilities are CN¥4.9B and CN¥2.0B respectively. Huaren Pharmaceutical's EBIT is CN¥305.8M making its interest coverage ratio 5.9. It has cash and short-term investments of CN¥120.1M.
Belangrijke informatie
34.8%
Verhouding schuld/eigen vermogen
CN¥986.74m
Schuld
| Rente dekkingsratio | 5.9x |
| Contant | CN¥120.10m |
| Aandelen | CN¥2.84b |
| Totaal verplichtingen | CN¥2.04b |
| Totaal activa | CN¥4.87b |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: 300110's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥1.4B).
Langlopende schulden: 300110's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥611.3M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 300110's net debt to equity ratio (30.5%) is considered satisfactory.
Schuld verminderen: 300110's debt to equity ratio has increased from 11.2% to 34.8% over the past 5 years.
Schuldendekking: 300110's debt is well covered by operating cash flow (39.9%).
Rentedekking: 300110's interest payments on its debt are well covered by EBIT (5.9x coverage).